Dr. Emmanuel Cruz Gorospe, MD

Dr. Gorospe practices at Abrazo Central Campus in Phoenix, Arizona, part of Tenet Healthcare.

Dr. Gorospe's NPI, 1225160427, was assigned on March 12, 2007. Dr. Gorospe graduated from University of the Philippines College of Medicine in 2005. Dr. Gorospe holds Texas license Q9362.

Dr. Gorospe's primary practice is Abrazo Central Campus, at 2000 West Bethany Home Road, Phoenix, AZ 85015 in Maricopa County. The practice phone is (602) 249-0212.

Dr. Gorospe's primary practice is Abrazo Central Campus in Phoenix, Arizona, part of Tenet Healthcare. Dr. Gorospe is also affiliated with Abrazo Scottsdale Campus. The medical group on file is Abrazo Medical Group. Dmand AI also links Dr. Gorospe to 3 more hospitals, 4 medical groups, 2 physician offices, 2 group practices and clinics and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorospe practices, 10 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gorospe's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gorospe is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gorospe's licenses on file in 10 states: Texas, Arizona, Ohio, Hawaii, Massachusetts, Pennsylvania, West Virginia, Michigan, Wisconsin and Minnesota.

CMS data shows 346 Medicare services from Dr. Gorospe across 7 procedure codes in 2022. Medicare paid $19,728 for them.

Across all payers, Dmand AI patient panel data puts Dr. Gorospe's median patient age at 63, with 51% women.

In 2022, Dr. Gorospe wrote 131 Medicare Part D claims. They cover 5 drugs, with $88,070 in total drug cost. In 2021, CMS named 328 claims across 8 drugs.

Dr. Gorospe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 42 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gorospe, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 76 papers to Dr. Gorospe, published from 2006 to 2022. 2013 was the busiest year, with 10. The most frequent topics are Barrett Esophagus, Esophageal Neoplasms and Adenocarcinoma. Dr. Gorospe has published most often in Ann Gastroenterol. Dr. Gorospe's most frequent co-authors are Cadman Lyle Leggett, MD, Louis M. Wong Kee Song, MD and David H. Bruining, MD.

Dmand AI links Dr. Gorospe to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Non-alcoholic Fatty Liver Disease and Fatty Liver. Open Payments lists research payments to Dr. Gorospe that name 1 trial.

CMS Open Payments shows 125 general payments to Dr. Gorospe from 38 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 42% of the total. Eli Lilly and Company paid the most, $3,000. It also lists 5 research payments totaling $1,648 in 2023, naming 1 clinical trial.

Dmand AI lists 4 awards for Dr. Gorospe. Dr. Gorospe serves on Annals of Gastroenterology.

Dr. Gorospe graduated from University of the Philippines College of Medicine in 2005. Dr. Gorospe is a member of ACG, ACP and ASGE.

Dr. Gorospe is in network with 19 carriers, including Aetna, United Healthcare and Cigna. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.